These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23241257)

  • 1. Adverse drug reactions in older adults: a retrospective study from pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):471-6. PubMed ID: 23241257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious adverse drug reactions in older adults notified to pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):465-70. PubMed ID: 23241256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
    Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
    Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse drug reactions in children. A series of 90 cases.
    Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
    Pinzón JF; Maldonado C; Díaz JA; Segura O
    Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab infusion reactions: French pharmacovigilance database analysis.
    Grandvuillemin A; Disson-Dautriche A; Miremont-Salamé G; Fourrier-Reglat A; Sgro C;
    J Oncol Pharm Pract; 2013 Jun; 19(2):130-7. PubMed ID: 23154574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced hyperglycemia: a study in the French pharmacovigilance database].
    Chebane L; Tavassoli N; Bagheri H; Montastruc JL;
    Therapie; 2010; 65(5):447-58. PubMed ID: 21144480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
    Choquet-Kastylevsky G; Vial T; Santolaria N; Nageotte A; Faure M; Claudy A; Descotes J
    Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.
    Hamilton H; Gallagher P; Ryan C; Byrne S; O'Mahony D
    Arch Intern Med; 2011 Jun; 171(11):1013-9. PubMed ID: 21670370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update of the French drug reaction assessment method].
    ; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
    Therapie; 2011; 66(6):517-25. PubMed ID: 22186077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.
    González-Rubio F; Calderón-Larrañaga A; Poblador-Plou B; Navarro-Pemán C; López-Cabañas A; Prados-Torres A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1287-94. PubMed ID: 21702073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced pancreatitis. A review of French spontaneous reports].
    Chebane L; Bagheri H; Hillaire-Buys D; Géniaux H; Yahioui N; Laroche ML; Cottin J; Spreux A; Mosquet B; Pecriaux C; Bellet F; Lambert A; Montastruc JL
    Rev Med Interne; 2015 Sep; 36(9):573-8. PubMed ID: 26045335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].
    Abadie D; Durrieu G; Roussin A; Montastruc JL;
    Therapie; 2013; 68(2):77-84. PubMed ID: 23773348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.